Warberg Asset Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Warberg Asset Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,772	Closed	-$66.2K	–	206
2026 Q1	$66.2K	Buy	+90,772	New	+$413K	0.01%	141
2025 Q3	–	Sell	-2,375	Closed	-$18.1K	–	217
2025 Q2	$18.1K	Buy	+2,375	New	+$37K	﹤0.01%	154

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Warberg Asset Management's RVPH Position: Q2 2026 in Review

Warberg Asset Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 90,772 shares — an estimated $66.2K sold.

Warberg Asset Management first reported a position in RVPH in Q2 2025 and held it in 2 quarters. The position peaked at $66.2K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Warberg Asset Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Warberg Asset Management sold 90,772 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $66.2K.
Warberg Asset Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2025 and held it in 2 quarters.
Warberg Asset Management's REVIVA PHARMA HLDGS INC position peaked at $66.2K in Q1 2026.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.